<code id='70B162364F'></code><style id='70B162364F'></style>
    • <acronym id='70B162364F'></acronym>
      <center id='70B162364F'><center id='70B162364F'><tfoot id='70B162364F'></tfoot></center><abbr id='70B162364F'><dir id='70B162364F'><tfoot id='70B162364F'></tfoot><noframes id='70B162364F'>

    • <optgroup id='70B162364F'><strike id='70B162364F'><sup id='70B162364F'></sup></strike><code id='70B162364F'></code></optgroup>
        1. <b id='70B162364F'><label id='70B162364F'><select id='70B162364F'><dt id='70B162364F'><span id='70B162364F'></span></dt></select></label></b><u id='70B162364F'></u>
          <i id='70B162364F'><strike id='70B162364F'><tt id='70B162364F'><pre id='70B162364F'></pre></tt></strike></i>

          Home / Wikipedia / explore

          explore


          explore

          author:hotspot    Page View:2588
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In